Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Sees Large Increase in Short Interest

Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) was the recipient of a significant increase in short interest in August. As of August 15th, there was short interest totalling 1,320,000 shares, an increase of 150.1% from the July 31st total of 527,700 shares. Currently, 5.9% of the shares of the stock are sold short. Based […]

Related Keywords

,Blackrock Inc ,Stratos Wealth Partners ,Geode Capital Management ,Eton Pharmaceuticals Inc ,Vanguard Group Inc ,Acuitas Investments ,Nasdaq ,Eton Pharmaceuticals Trading Down ,Eton Pharmaceuticals ,News Ratings For Eton Pharmaceuticals Daily ,Get Free Report ,Capital Management ,Pharmaceuticals Trading Down ,Carglumic Acid ,N Acetylglutamate Synthase ,Betaine Anhydrous ,Eton Pharmaceuticals Daily ,Nasdaq Eton ,Eton ,Medical ,Stocks ,Options ,Put ,Call ,